Literature DB >> 26864380

Awareness of Hepatitis C Virus Seropositivity and Chronic Infection in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).

Mark H Kuniholm1, Molly Jung2, Julia Del Amo3, Gregory A Talavera4, Bharat Thyagarajan5, Ronald C Hershow6, Oriana M Damas7, Robert C Kaplan2.   

Abstract

Few population-based studies have assessed awareness of hepatitis C virus (HCV) seropositivity and chronic infection. We report awareness of HCV seropositivity and chronic infection and correlates of awareness in a multi-city (Bronx, Miami, Chicago, and San Diego) community-dwelling population sample of United States (US) Hispanics/Latinos recruited during 2008-2011. Included were 260 HCV-seropositive participants, among whom 190 had chronic HCV. Among those with chronic HCV, 46 % had been told by a doctor that they had liver disease and 32 % had been told that they had HCV-related liver disease. Among those with chronic HCV who also lacked health insurance (37 % of those with chronic HCV), only 8 % had been told that they had HCV-related liver disease. As compared with the uninsured, those with insurance were over five times more likely to be aware of having HCV-related liver disease (44 %). Sex, age, education, city of residence, and birthplace were not associated with HCV awareness. Less than half of Hispanics/Latinos were aware of their HCV chronic infection. Lack of health insurance may be an important barrier to HCV awareness in this population.

Entities:  

Keywords:  Awareness; Hepatitis C virus; Hispanic; Latino; United States

Mesh:

Year:  2016        PMID: 26864380      PMCID: PMC4980290          DOI: 10.1007/s10903-016-0350-1

Source DB:  PubMed          Journal:  J Immigr Minor Health        ISSN: 1557-1912


  17 in total

1.  Estimating the relative risk in cohort studies and clinical trials of common outcomes.

Authors:  Louise-Anne McNutt; Chuntao Wu; Xiaonan Xue; Jean Paul Hafner
Journal:  Am J Epidemiol       Date:  2003-05-15       Impact factor: 4.897

2.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection.

Authors:  Richard K Sterling; Eduardo Lissen; Nathan Clumeck; Ricard Sola; Mendes Cassia Correa; Julio Montaner; Mark S Sulkowski; Francesca J Torriani; Doug T Dieterich; David L Thomas; Diethelm Messinger; Mark Nelson
Journal:  Hepatology       Date:  2006-06       Impact factor: 17.425

3.  Assessing health care services used by California's undocumented immigrant population in 2010.

Authors:  Nadereh Pourat; Steven P Wallace; Max W Hadler; Ninez Ponce
Journal:  Health Aff (Millwood)       Date:  2014-05       Impact factor: 6.301

4.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

5.  Design and implementation of the Hispanic Community Health Study/Study of Latinos.

Authors:  Paul D Sorlie; Larissa M Avilés-Santa; Sylvia Wassertheil-Smoller; Robert C Kaplan; Martha L Daviglus; Aida L Giachello; Neil Schneiderman; Leopoldo Raij; Gregory Talavera; Matthew Allison; Lisa Lavange; Lloyd E Chambless; Gerardo Heiss
Journal:  Ann Epidemiol       Date:  2010-08       Impact factor: 3.797

6.  Sample design and cohort selection in the Hispanic Community Health Study/Study of Latinos.

Authors:  Lisa M Lavange; William D Kalsbeek; Paul D Sorlie; Larissa M Avilés-Santa; Robert C Kaplan; Janice Barnhart; Kiang Liu; Aida Giachello; David J Lee; John Ryan; Michael H Criqui; John P Elder
Journal:  Ann Epidemiol       Date:  2010-08       Impact factor: 3.797

7.  Health care access, use of services, and experiences among undocumented Mexicans and other Latinos.

Authors:  Alexander N Ortega; Hai Fang; Victor H Perez; John A Rizzo; Olivia Carter-Pokras; Steven P Wallace; Lillian Gelberg
Journal:  Arch Intern Med       Date:  2007-11-26

8.  Effectiveness of hepatitis C treatment with pegylated interferon and ribavirin in urban minority patients.

Authors:  Paul Feuerstadt; Ari L Bunim; Heriberto Garcia; Jordan J Karlitz; Hatef Massoumi; Amar J Thosani; Andrew Pellecchia; Allan W Wolkoff; Paul J Gaglio; John F Reinus
Journal:  Hepatology       Date:  2010-04       Impact factor: 17.425

9.  Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study.

Authors:  Eric Lawitz; Mark S Sulkowski; Reem Ghalib; Maribel Rodriguez-Torres; Zobair M Younossi; Ana Corregidor; Edwin DeJesus; Brian Pearlman; Mordechai Rabinovitz; Norman Gitlin; Joseph K Lim; Paul J Pockros; John D Scott; Bart Fevery; Tom Lambrecht; Sivi Ouwerkerk-Mahadevan; Katleen Callewaert; William T Symonds; Gaston Picchio; Karen L Lindsay; Maria Beumont; Ira M Jacobson
Journal:  Lancet       Date:  2014-07-28       Impact factor: 79.321

10.  Body mass index, sex, and cardiovascular disease risk factors among Hispanic/Latino adults: Hispanic community health study/study of Latinos.

Authors:  Robert C Kaplan; M Larissa Avilés-Santa; Christina M Parrinello; David B Hanna; Molly Jung; Sheila F Castañeda; Arlene L Hankinson; Carmen R Isasi; Orit Birnbaum-Weitzman; Ryung S Kim; Martha L Daviglus; Gregory A Talavera; Neil Schneiderman; Jianwen Cai
Journal:  J Am Heart Assoc       Date:  2014-07-09       Impact factor: 5.501

View more
  5 in total

1.  Monitoring the hepatitis C care cascade using administrative claims data.

Authors:  Cheryl Isenhour; Susan Hariri; Claudia Vellozzi
Journal:  Am J Manag Care       Date:  2018-05       Impact factor: 2.229

2.  Gaps in Viral Hepatitis Awareness in the United States in a Population-based Study.

Authors:  Kali Zhou; Norah A Terrault
Journal:  Clin Gastroenterol Hepatol       Date:  2019-06-04       Impact factor: 11.382

3.  Sub-optimal Testing and Awareness of HCV and HBV Among High Risk Individuals at an Underserved Safety-Net Hospital.

Authors:  Robert J Wong; Brendan Campbell; Benny Liu; Rachel Baden; Taft Bhuket
Journal:  J Community Health       Date:  2018-02

4.  Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment.

Authors:  Robert J Wong; Mamta K Jain; George Therapondos; Mitchell L Shiffman; Onkar Kshirsagar; Christopher Clark; Mae Thamer
Journal:  J Clin Exp Hepatol       Date:  2019-09-20

5.  Funding of Hispanic/Latino Health-Related Research by the National Institutes of Health: An Analysis of the Portfolio of Research Program Grants on Six Health Topic Areas.

Authors:  M Larissa Avilés-Santa; Laura Hsu; Tram Kim Lam; S Sonia Arteaga; Ligia Artiles; Sean Coady; Lawton S Cooper; Jennifer Curry; Patrice Desvigne-Nickens; Holly L Nicastro; Adelaida Rosario
Journal:  Front Public Health       Date:  2020-08-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.